192 related articles for article (PubMed ID: 36841851)
1. Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
Zhu P; Du XL; Hwang LY; Lairson D; Li R; Esquenazi Y; Zhu JJ
Sci Rep; 2023 Feb; 13(1):3266. PubMed ID: 36841851
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
3. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme.
Lai R; Hershman DL; Doan T; Neugut AI
Neuro Oncol; 2010 Feb; 12(2):190-8. PubMed ID: 20150386
[TBL] [Abstract][Full Text] [Related]
4. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
5. National Trends for Reoperation in Older Patients with Glioblastoma.
Chen YR; Sole J; Ugiliweneza B; Johnson E; Burton E; Woo SY; Koutourousiou M; Williams B; Boakye M; Skirboll S
World Neurosurg; 2018 May; 113():e179-e189. PubMed ID: 29427817
[TBL] [Abstract][Full Text] [Related]
6. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.
Barnholtz-Sloan JS; Maldonado JL; Williams VL; Curry WT; Rodkey EA; Barker FG; Sloan AE
J Neurooncol; 2007 Nov; 85(2):171-80. PubMed ID: 17530174
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma.
Barnholtz-Sloan JS; Williams VL; Maldonado JL; Shahani D; Stockwell HG; Chamberlain M; Sloan AE
J Neurosurg; 2008 Apr; 108(4):642-8. PubMed ID: 18377240
[TBL] [Abstract][Full Text] [Related]
9. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
Zinn PO; Colen RR; Kasper EM; Burkhardt JK
Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
11. Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.
Goldman DA; Reiner AS; Diamond EL; DeAngelis LM; Tabar V; Panageas KS
Neurooncol Adv; 2021; 3(1):vdaa159. PubMed ID: 33506202
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
14. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
[TBL] [Abstract][Full Text] [Related]
15. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
[TBL] [Abstract][Full Text] [Related]
16. Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract][Full Text] [Related]
17. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
[TBL] [Abstract][Full Text] [Related]
18. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
20. Time to Surgery and Breast Cancer Survival in the United States.
Bleicher RJ; Ruth K; Sigurdson ER; Beck JR; Ross E; Wong YN; Patel SA; Boraas M; Chang EI; Topham NS; Egleston BL
JAMA Oncol; 2016 Mar; 2(3):330-9. PubMed ID: 26659430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
